课题基金 / 基金详情

Innovative metabolic mapping to predict and enhance the response of targeted anti-cancer therapies

Innovative metabolic mapping to predict and enhance the response of targeted anti-cancer therapies
创新的代谢图谱可预测和增强靶向抗癌疗法的反应
批准号:
MR/W012030/1
负责人:
George Poulogiannis
金额:
$192.26万
依托单位国家:
英国
项目类别:
Fellowship
财政年份:
2022
资助国家:
英国
项目状态:
未结题
起止时间:
2022 至 --

项目摘要

项目成果

George Poulogiannis的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Evidence suggests that the way cells consume and process nutrients, collectively known as metabolism, differs between healthy and tumour cells and can even change the way they communicate with adjacent cells, grow, and importantly, respond to therapy. Nutrient availability in the environment where the tumour is growing can also have a fundamental impact on the effectiveness of anti-cancer therapies. This project will draw on the strengths of innovative tools and methods to track the metabolism of breast cancer tumours and pre-clinical models, and identify the metabolic determinants that guide the response to anti-cancer therapies. In this context, it will assist with gaining insight into how certain drugs affect tumour metabolism, and ultimately, how the metabolism of a tumour and its surrounding affect its response to therapy. In the longer term this knowledge will expose weaknesses in the tumour's armour and unveil more effective therapeutic strategies where diet and metabolic targets could help circumvent drug resistance and slow down tumour growth.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Tracking metabolic reprogramming through stable isotope-resolved metabolomics
  • 批准号:
    MR/X013715/1
  • 项目类别:
    Research Grant
  • 资助金额:
    $49.8万
  • 财政年份:
    2022
  • 负责人:
    George Poulogiannis
  • 依托单位:
国内基金
海外基金
α-酮戊二酸调控ACMSD介导犬尿氨酸通路代谢重编程在年龄相关性听力损失中的作用及机制研究
  • 批准号:
    82371150
  • 项目类别:
    面上项目
  • 资助金额:
    49.00万元
  • 批准年份:
    2023
  • 负责人:
    侯书乐
  • 依托单位:
多囊卵巢综合征中甲酰肽受体2调控小胶质细胞代谢重编程导致GnRH神经元过度激活及HPO轴异常的病理机制研究
  • 批准号:
    82370797
  • 项目类别:
    面上项目
  • 资助金额:
    49.00万元
  • 批准年份:
    2023
  • 负责人:
    陶弢
  • 依托单位:
NPC1调控肾上腺皮质激素分泌影响代谢稳态的机制研究
  • 批准号:
    82370796
  • 项目类别:
    面上项目
  • 资助金额:
    49.00万元
  • 批准年份:
    2023
  • 负责人:
    蒋怡然
  • 依托单位:
衰老上皮细胞FABP4调控HSDL2致脂肪酸代谢失衡在BPH发病中的机制研究
  • 批准号:
    82370774
  • 项目类别:
    面上项目
  • 资助金额:
    49.00万元
  • 批准年份:
    2023
  • 负责人:
    阮渊
  • 依托单位: